Kaiser Permanente Ventures
Kaiser Permanente Ventures is a corporate venture capital firm investing in healthcare companies.
Business Model:
Revenue: $15M
Employees: 2-10
Rankings
Industries / Tags:
Detailed Kaiser Permanente Ventures Information
Geographic Data
Address: 1 Kaiser Plaza
City: Oakland
State: CA
Zip: 94612
Country: US
Financial Info
Stage:
Raised Last:
$0
Raised Total:$141M
Social
Facebook
Twitter
Linkedin
Crunchbase
Metrics
0Website Global Rank
0Website Monthly Traffic
Twitter Followers
Description
Kaiser Permanente Ventures, the corporate venture capital arm of Kaiser Permanente, is dedicated to forming effective partnerships with innovative companies. Kaiser Permanente Ventures invests predominantly in HCIT and services, as well as diagnostics, drug delivery and therapeutic medical devices.
Contact Phone:
Contact Email:
| Announced Date | Company | Transaction | Money Raised |
|---|---|---|---|
| 1/2013 | Nordic | Funding Round | 38.3M |
| 9/2021 | NOCD | Series B | 0 |
| 6/2021 | Protenus | Series D | 0 |
| 1/2018 | Protenus | Series B | 11M |
| 4/2005 | BDNA | Series C | 12.5M |
| 6/2010 | Predictive Biosciences | Series C | 25M |
| 8/2020 | Ginger | Series D | 0 |
| 1/2012 | CytoPherx | Series C | 34M |
| 1/2015 | Kit Check | Series B | 12M |
| 5/2021 | Groups Recover Together | Series C | 60M |
| 4/2014 | Vapotherm | Series B | 0 |
| 8/2005 | NextWeb | Series E | 3.5M |
| 8/2019 | Protenus | Series C | 0 |
| 4/2013 | iRhythm Technologies | Series D | 16M |
| 1/2012 | iRhythm Technologies | Private Equity Round | 12.2M |
| 1/2020 | Vesta Healthcare | Series A | 30M |
| 6/2016 | Kit Check | Series C | 0 |
| 6/2004 | Proteus Digital Health | Series B | 6.3M |
| 9/2010 | Accumetrics | Venture Round | 0 |
| 6/2013 | Movable | Seed | 1.9M |
| 8/2005 | Adiana | Series D | 23M |
| 10/2009 | Accumetrics | Series E | 0 |
| 1/2012 | Transcend Medical | Series B | 16M |
| 4/2013 | Nordic | Venture Round | 5M |
| 7/2016 | Big Health | Series B | 0 |
| 12/2004 | Radianse | Venture Round | 2M |
| 12/2014 | Ginger | Series B | 20M |
| 4/2013 | AtheroMed | Private Equity Round | 6M |
| 7/2016 | Torax Medical | Series E | 0 |
| 11/2022 | Validic | Venture Round | 12M |
| 11/2020 | Kate Farms | Series B | 51M |
| 6/2012 | Oxford Immunotec | Equity | 28M |
| 2/2016 | CareGuardian | Series B | 5M |
| 1/2015 | Ingenious Med | Venture Round | - |
| 1/2018 | Genome Medical | Series A | 11M |
| 11/2011 | Xanitos | Venture Round | 0 |
| 6/2011 | Transcend Medical | Series B | 51M |
| 11/2001 | NextWeb | Series C | - |
| 11/2003 | NeoGuide Systems | Series B | 0 |
| 2/2019 | Health Catalyst | Series F | 0 |
| 4/2014 | Omada Health | Series B | 23M |
| 3/2012 | AtheroMed | Series D | 4.5M |
| 4/2010 | Hemosphere | Series A | 9.3M |
| 1/2008 | Arbor Surgical Technologies | Series C | 0 |
| 8/2020 | Freenome | Series C | 270M |
| 8/2022 | Everytable | Series C | 0 |
| 9/2011 | Valeritas | Series C | 150M |
| 7/2021 | Osso VR | Series B | 0 |
| 9/2009 | ValenTx | Series B | 0 |
| 10/2008 | Predictive Biosciences | Series B | 21.8M |
| 4/2022 | IntelyCare | Series C | 0 |
| 1/2022 | Big Health | Series C | 0 |
| 4/2014 | Transcend Medical | Series C | 0 |
| 4/2007 | Bacchus Vascular | Venture Round | 6.5M |
| 8/2009 | Silverlink Communications | Series D | 5M |
| 9/2016 | Chrono Therapeutics | Series B | 47.6M |
| 1/2007 | Calypso Medical | Series D | 42.2M |
| 7/2012 | Agile Therapeutics | Series C | 0 |
| 6/2010 | Agile Therapeutics | Series B | 0 |
| 9/2013 | Xanitos | Venture Round | 0 |
| 2/2009 | Arcxis Biotechnologies | Series B | - |
| 7/2019 | Nuvolo | Series B | 12M |
| 9/2022 | Kate Farms | Series C | 75M |
| 12/2015 | Vidyo | Series E | 15M |
| 2/2019 | Health Catalyst | Debt Financing | 0 |
| 3/2020 | Ordr | Series B | 6M |
| 6/2016 | Bluesight | Series C | 20.4M |
| 2/2020 | IntelyCare | Series B | 45M |
| 3/2021 | Evidation Health | Series E | 153M |
| 1/2015 | Bluesight | Series B | 12M |
| 4/2015 | Validic | Series B | 12.5M |
| 6/2020 | Big Health | Series B | 39M |
| 11/2020 | Everytable | Series B | 0 |
| 3/2022 | Osso VR | Series C | 0 |
| 6/2010 | Baxano | Series C | 30M |
| 1/2014 | Health Catalyst | Series C | 0 |
| 4/2013 | Vapotherm | Series A | 0 |
| 10/2022 | NorthOne | Series B | 0 |
| 6/2022 | Ordr | Series C | 0 |
| 2/2008 | Accumetrics | Series D | 0 |
| 11/2015 | Vapotherm | Series C | 0 |
| 1/2005 | GeneOhm Sciences | Series C | 0 |
| 2/2008 | Zonare Medical Systems | Equity | 30M |
| 6/2012 | TriVascular | Series D | 60M |
| 7/2014 | Valeritas | Series D | 45M |
| 7/2019 | Freenome | Series B | 160M |
| 6/2012 | Astute Medical | Series C | 40.4M |
| 8/2021 | Genome Medical | Series C | 0 |
| 9/2019 | Ginger | Series C | 0 |
| 3/2021 | DexCare | Series A | 0 |
| 1/2023 | NOCD | Series B | 0 |
| 7/2017 | Protenus | Series A | 3M |
| 3/2021 | Nuvolo | Series C | 32M |
| 3/2015 | Health Catalyst | Series D | 0 |
| 7/2015 | Vapotherm | Series C | 0 |
| 11/2017 | Collective Medical Technologies | Series A | 47.5M |
| 6/2023 | DexCare | Series C | 0 |
| 8/2021 | Abogen Biosciences | Series C | 0 |
| 11/2013 | TriVascular | Series E | 0 |
| 11/2018 | Vesta Healthcare | Series A | 10M |
| 11/2007 | Vapotherm | Series E | 11.3M |
| 8/2008 | Vapotherm | Series F | 20.5M |
| 1/2005 | CHF Solutions | Venture Round | 22.9M |
| 9/2012 | Torax Medical | Series D | 0 |
| 9/2020 | Osso VR | Series A | 14M |
| 3/2013 | Health Catalyst | Series B | 0 |
| 11/2002 | NextWeb | Series D | 1.5M |
| 9/2014 | MetricStream | Private Equity Round | 60M |
| 5/2010 | Oxford Immunotec | Series D | 26M |
| 7/2020 | Genome Medical | Series B | 0 |
| 3/2012 | GluMetrics | Venture Round | 13.3M |
| 8/2022 | Everytable | Series C | 0 |
| 6/2022 | Ordr | Series C | 0 |
| 4/2022 | IntelyCare | Series C | 0 |
| 3/2022 | Osso VR | Series C | 0 |
| 1/2022 | Big Health | Series C | 0 |
| 9/2021 | NOCD | Series B | 0 |
| 8/2021 | Genome Medical | Series C | 0 |
| 8/2021 | Abogen Biosciences | Series C | 0 |
| 7/2021 | Osso VR | Series B | 0 |
| 6/2021 | Protenus | Series D | 0 |
Startup Industries
Startup Locations
Portfolio Current Status
Portfolio Employee Count
| Name | Price |
|---|
| Name | Size | Announced Date |
|---|
